z-logo
open-access-imgOpen Access
Impact of Thrombus Length on Outcomes After Intra-Arterial Aspiration Thrombectomy in the THERAPY Trial
Author(s) -
Albert J. Yoo,
Pooja Khatri,
J Mocco,
Osama O. Zaidat,
Rishi Gupta,
Donald Frei,
Demetrius K. Lopes,
Harish Shownkeen,
Olvert A. Berkhemer,
Denise Meyer,
S Hak,
S Kuo,
Hope Buell,
Arani Bose,
Siu Po Sit,
Rüdiger von Kummer
Publication year - 2017
Publication title -
stroke
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.397
H-Index - 319
eISSN - 1524-4628
pISSN - 0039-2499
DOI - 10.1161/strokeaha.116.016253
Subject(s) - medicine , interquartile range , thrombolysis , modified rankin scale , stroke (engine) , odds ratio , confidence interval , intracerebral hemorrhage , tissue plasminogen activator , adverse effect , thrombus , randomized controlled trial , surgery , univariate analysis , fibrinolytic agent , cardiology , ischemia , ischemic stroke , multivariate analysis , subarachnoid hemorrhage , myocardial infarction , mechanical engineering , engineering
Increasing thrombus length (TL) impedes recanalization after intravenous (IV) thrombolysis. We sought to determine whether the clinical benefit of aspiration thrombectomy relative to IV r-tPA (recombinant tissue-type plasminogen activator) may be greater at longer TL.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom